PAIN TRIGGERS
Vyvanse wears off too quickly or causes a severe afternoon crash/drained feeling.
Difficulty balancing cognitive processing/mood benefits with actual executive execution between different medications.
SaaS· ADHD patientsPain 8.00/10WTP 7.0/10Market 8.0/10Validation 8.0Confidence 90%Jun 23, 2026
FocusTitrate: ADHD Symptom and Side-Effect Tracker for Medication Optimisation
ADHD patients suffer through months of unpredictable, draining trial-and-error to find the right medication because stimulants affect individual body chemistries radically differently, causing early crashes, extreme lethargy, or separate cognitive vs. executive effects.
adhdanalyticshealthcaremobile-appproductivitysaasworkflow
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD patients struggle to find the right medication and dosage because different stimulants have drastically varying efficacy, duration, and side effects unique to each individual's body chemistry.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Vyvanse vs Adderall
ADHD1012
The vyvanse seems to mostly help me with mood regulation more than executive function. The adderall helps with the executive function and ability to focus.
commentI'm currently on 40mg Vyvanse + 20mg Adderall (10mg in the morning and another 10mg in the early afternoon) The vyvanse seems to mostly help me with mood regulation more than executive function. The adderall helps with the executive function and ability to focus.
generic vyvanse takes forever to work on me, like 5-6 hrs. and i have so much stomach bloating/gas/cramps and constipation with it.
commentgeneric vyvanse takes forever to work on me, like 5-6 hrs. and i have so much stomach bloating/gas/cramps and constipation with it. ive switched to adderall IR. it takes about an hour to feel its effect and i like how i can structure my day given that it is consistent with timing.
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patientsA D H D Patients Adjusting Stimulant Regimens
Individuals trying to find their ideal ADHD medication type and dosage who suffer from early afternoon crashes, unpredictable side effects, or mismatched cognitive benefits.
Context
Determine the ideal ADHD medication regimen (Vyvanse vs. Adderall or alternatives) and dosage strategy to maintain consistent focus and energy throughout the day without severe side effects or early afternoon crashes.
Combining Vyvanse with afternoon Adderall 'boosters' to bridge the gap when the primary medication wears off.
Switching back to Immediate Release (IR) medications to have better control and consistency over daily scheduling.
Current Workarounds
Manually logging notes in generic phone apps or journals
Sifting through crowdsourced anecdotal data and advice on Reddit
Using afternoon immediate-release booster pills blindly without data
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard once-daily Vyvanse dosing fails to provide all-day coverage, leaving patients exhausted by the afternoon.
Medications act unpredictably per individual, with some causing paradoxical extreme tiredness (narcolepsy-like symptoms), long onset delays, or gastrointestinal distress.
Finding a working treatment involves months of painful trial-and-error tweaking with prescribers.
OPPORTUNITY & VALUE
Why Now
Repeated complaints focus heavily on Vyvanse wearing off too early in the afternoon and the profound friction of figuring out which stimulant addresses mood versus focus mechanics.
Value Proposition
Unlike generic mood diaries or habit trackers, FocusTitrate is engineered specifically around stimulant pharmacokinetics—tracking the distinct split between mood regulation and executive execution while directly mapping exact crash timestamps.
Product Direction
A dedicated, lightweight symptom and side-effect logging application specifically designed for ADHD stimulant tracking. It enables users to easily chart their energy levels, focus, mood, and physical side effects throughout the day, automatically plotting drug duration curves to generate a comprehensive, exportable data report that helps psychiatrists perfectly calibrate dosages and booster timing.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9/moBilled monthly during the calibration phase; cancel anytime
Model
SaaS subscription
WILLINGNESS TO PAY
Users spend months suffering from lost productivity and expensive doctor visits; a precise data tool that cuts weeks off the painful trial-and-error titration process easily justifies a $9 cost.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“From unpredictable stimulant crashes to clear, doctor-ready dosage charts in 30 days.”
A dedicated, lightweight symptom and side-effect logging application specifically designed for ADHD stimulant tracking. It enables users to easily chart their energy levels, focus, mood, and physical side effects throughout the day, automatically plotting drug duration curves to generate a comprehensive, exportable data report that helps psychiatrists perfectly calibrate dosages and booster timing.
Core Features
One-tap daily logging for focus, energy, and mood at customizable intervals
Specific side-effect trackers (e.g., 'crashing', 'narcoleptic fatigue', 'GI distress')
Medication intake logging with split-dose and booster support
Exportable 'Doctor Consultation Report' summarizing efficacy windows and crash times
Weekly Roadmap
1
W1-W2
Core telemetry and medication logging architecture functional.
- •Build fast authentication and secure database encryption mapping
- •Implement rapid-input logger for daily focus, energy, and stimulant timing
- •Design dashboard showing real-time timeline of medication inputs
2
W3-W4
Pharmacokinetic trend-mapping and push-notification triggers complete.
- •Develop background data engine calculating duration averages and crash zones
- •Implement ultra-low-friction push notifications reminding users to log focus during projected crash windows
- •Build specific side-effect modules for executive blocks and physical symptoms
3
W5
Exportable medical summary document and closed beta onboarding finalized.
- •Design crisp PDF/Web export containing cleanly visualized data charts for psychiatrists
- •Deploy secure Stripe integration for billing handling
- •Onboard 15 active beta testers recruited directly from ADHD online networks
4
W6
Public launch and performance observation.
- •Publish open launch announcement across targeted neurodivergent digital spaces
- •Collect direct feedback on logging friction to optimize UX simplicity
- •Evaluate conversion and user retention trends through week one
Launch Strategy
Engage via dedicated ADHD communities and subreddits (e.g., r/ADHD, r/Vyvanse, r/Adderall) by sharing open-source tracking templates, and establish partnerships with private ADHD coaching networks and progressive psychiatrists.
RISKS & ASSUMPTIONS
Top Risks
Adherence drop-off from target users
The target demographic inherently struggles with routines, meaning complex or tedious logging flows will lead to immediate abandonment.
Medical advice liability
If the software provides automated recommendations on dosage modifications, it crosses into regulated medical device territory.
Data privacy sensitivities
Users are inputting sensitive medical and controlled-substance information, requiring robust encryption and explicit data privacy standards.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 8/10 against 3 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "analytics", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "FocusTitrate: ADHD Symptom and Side-Effect Tracker for Medication Optimisation" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.